top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
🎯 How to Find and Export Contacts in BiopharmIQ: A Step-by-Step Guide for Sales & Marketing Teams
BiopharmIQ is designed to empower sales and marketing professionals in the life sciences industry with targeted lists of companies and...
BiopharmIQ
Biopharma Funding Activity from April 29th - May 3rd 2024
The race for funding never stops in biopharma. 48 companies pulled in a massive amount of capital through private deals, post-IPO...
May 7, 2024
🧬 Biopharma Bite Sized News 🍪 April 29th - May 3rd
INGREZZA FDA approval & 9 more major updates... Want a list of segmented biopharma companies or access to our online platform? Get more...
May 5, 2024
M&As announced YTD in 2024
M&A highlights from last week…👇 YTD Summary: Number Announced: 28 Q1 2024 # Announced: 18 Q2 2024 # Announced: 10 Mariana...
May 3, 2024
Biopharma Funding Activity from April 22-26th 2024
Last week saw significant activity in biopharma funding, with 49 public and private events. Several companies secured substantial...
Apr 30, 2024
🧬 Biopharma Bite Sized News 🍪 April 22nd - April 26th
BEQVEZ™ Gene Tx Approved & 9 more major updates...👇 Want a list of segmented biopharma companies or access to our online platform? Get...
Apr 26, 2024
Biopharma Funding Activity from April 15-19th 2024
From early-stage seed rounds to substantial public offerings, the biopharma sector witnessed diverse funding activity between April...
Apr 22, 2024
Major M&As Announced Recently - Late 2023 / Early 2024
The year 2024 continues to see significant mergers and acquisitions (M&A) activity in the biopharma sector. Here's a breakdown of 17...
Apr 19, 2024
Biopharma approvals, new data, M&A activity, and more - April 12th 2024
Immunotherapy company acquired for >$4B & 10 more updates...👇 Want a list of segmented biopharma companies or access to our online...
Apr 12, 2024
Recent Biopharma Funding Activity - April 8th
Check out the following recent activity in the biopharma funding space. Take a closer look at 43 notable updates for this week: Want to...
Apr 8, 2024
Biopharma approvals, new data, M&A activity, and more - April 5th 2024
$13B acquisition deal + 10 more major updates...👇 Want a list of segmented biopharma companies or access to our online platform? Get...
Apr 5, 2024
Major acquisitions announced YTD in 2024
2024 has seen a slew of mergers and acquisitions. Here's a breakdown of 10 major deals within the pharmaceutical and biotechnology...
Apr 2, 2024
Recent Biopharma Funding Activity - April 1st
Check out the following recent activity in the biopharma funding space. This mix of private investments and public grants fuels important...
Apr 1, 2024
Biopharma approvals, new data, M&A activity, and more - March 29th 2024
Oral dual GLP-1/GIP obesity data + 14 more major updates...👇 🎯 → Approvals 🔬 → New data 🤝 → M&A activity Merck 🎯 FDA approved...
Mar 29, 2024
Biopharma approvals, new data, M&A activity, and more - March 22nd 2024
FDA approved gene tx for children w/ early-onset MLD + 13 updates...👇 Optinose 🎯 FDA approved XHANCE, the first and only medication...
Mar 22, 2024
Recent Biotech Funding Activity - March 18th
Check out the following recent activity in the biopharma funding space. This mix of private investments and public grants fuels...
Mar 18, 2024
Biopharma Approvals, New Data, M&A activity, and more...
First U.S. NASH/MASH approval + 12 updates...👇 Madrigal Pharmaceuticals 🎯 FDA Approved Rezdiffra™ (resmetirom) for the treatment of...
Mar 15, 2024
Recent Biopharma Funding Updates
Public and private funding events 👇 – Private Company Funding Rounds – Tenomix 🏦 Closed $2M seed funding round. Kenai Therapeutics 🏦...
Mar 4, 2024
3 Key Insights From FDA’s 1st Review of Gene Editing
BACKGROUND 1st Gene Editing AdCom On 10/31/23 an FDA AdCom met to discuss the safety of VRTX/CRSP’s exa-cel (CTX001) to reduce or...
Nov 21, 2023
Biopharma Bite Sized News - July 10th to 14th 2023
Cell therapy data, cancer trial safety-induced hold, potential mergers, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...
Jul 14, 2023
Biopharma Bite Sized News - July 3rd to 7th 2023
Alzheimer's FDA approval, atopic dermatitis data, new Alzheimer's studies, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor?...
Jul 7, 2023
Please fill out the following information along with your message.
bottom of page